First patients vaccinated in clinical trial of HIV experimental vaccine that uses Moderna’s mRNA technology
By Anokhi Saklecha, CNN The first participants have been vaccinated in a Phase 1 clinical trial of an experimental HIV vaccine that utilizes Moderna’s mRNA technology, the company announced last week. The trial, titled IAVI G002, is being conducted in partnership with IAVI, a nonprofit scientific research organization. It is testing a vaccine that delivers
Continue Reading